Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers

Human rhinovirus (HRV) infections are usually self-limited but may be associated with serious consequences, particularly in those with asthma and chronic respiratory disease. Effective antiviral agents are needed for preventing and treating HRV illnesses. Ruprintrivir (Agouron Pharmaceuticals, Inc.,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Hayden, Frederick G., Turner, Ronald B., Gwaltney, Jack M., Chi-Burris, Kathy, Gersten, Merril, Hsyu, Poe, Patick, Amy K., Smith, George J., Zalman, Leora S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2003
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296196/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14638501/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.12.3907-3916.2003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi